blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1124540

EP1124540 - DOSAGE FORMS CONTAINING TASTE MASKED ACTIVE AGENTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.09.2007
Database last updated on 03.05.2025
Most recent event   Tooltip08.01.2010Lapse of the patent in a contracting state
New state(s): CY
published on 10.02.2010  [2010/06]
Applicant(s)For all designated states
Biovail Laboratories International S.r.l.
Chelston Park, Building 2 Collymore Rock
St. Michael BH1 / BB
[N/P]
Former [2007/18]For all designated states
Biovail Laboratories International S.R.L.
Chelston Park, Building 2 Collymore Rock
St. Michael BH1 / BB
Former [2001/34]For all designated states
Biovail Technologies Ltd
14555 Avion at Lakeside
Chantilly, VA 20151 / US
Inventor(s)01 / MEZAACHE, Djelila
8609 Accokeek Street
Laurel, MD 20724 / US
02 / RAIDEN, Michael, G.
6370 Snickersville Tpk.
Purcellville, VA 20132-4919 / US
03 / SANGHVI, Pradeepkumar, P.
2515 Isham Randolph Drive
Herndon, VA 20171 / US
04 / SZEDLOCK, Scott, J.
20668 Suffolk Court
Riverside, California 92508 / US
 [2001/44]
Former [2001/34]01 / MEZAACHE, Djelila
8609 Accokeek Street
Laurel, MD 20724 / US
02 / RAIDEN, Michael, G.
6370 Snickersville Tpk.
Purcellville, VA 20132-4919 / US
03 / SANGHVI, Pradeepkumar, P.
2515 Isham Randolph Drive
Herndon, VA 20171 / US
04 / SZEDLOCK, Scott, J.
4447 Fairstone Drive
Fairfax, VA 22033 / US
Representative(s)Burford, Anthony Frederick
Beck Greener
Fulwood House
12 Fulwood Place
London
WC1V 6HR / GB
[N/P]
Former [2001/34]Burford, Anthony Frederick
W.H. Beck, Greener & Co. 7 Stone Buildings Lincoln's Inn
London WC2A 3SZ / GB
Application number, filing date99971312.626.10.1999
[2001/34]
WO1999US25059
Priority number, dateUS1998018350130.10.1998         Original published format: US 183501
[2001/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0025755
Date:11.05.2000
Language:EN
[2000/19]
Type: A1 Application with search report 
No.:EP1124540
Date:22.08.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 11.05.2000 takes the place of the publication of the European patent application.
[2001/34]
Type: B1 Patent specification 
No.:EP1124540
Date:22.11.2006
Language:EN
[2006/47]
Search report(s)International search report - published on:EP11.05.2000
ClassificationIPC:A61K9/26
[2006/10]
CPC:
A61K9/0056 (EP,US); A61K9/2081 (EP,US)
Former IPC [2004/43]A61K9/26, A61K31/165, A61K31/167
Former IPC [2004/03]A61K9/26, A61K31/165
Former IPC [2001/34]A61K9/26
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/34]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:DOSIERUNGSFORMEN ENTHALTEND GESCHMACKSMASKIERTEN WIRKSTOFFEN[2004/43]
English:DOSAGE FORMS CONTAINING TASTE MASKED ACTIVE AGENTS[2001/34]
French:FORMES GALENIQUES CONTENANT DES PRINCIPES ACTIFS AU GOUT MASQUE[2001/34]
Former [2001/34]DOSISFORMEN, DIE GESCHMAKSMASKIERTE WIRKSTOFFE ENTHALTEN
Entry into regional phase29.05.2001National basic fee paid 
29.05.2001Designation fee(s) paid 
29.05.2001Examination fee paid 
Examination procedure30.05.2000Request for preliminary examination filed
International Preliminary Examining Authority: US
29.05.2001Examination requested  [2001/34]
31.05.2001Amendment by applicant (claims and/or description)
15.12.2003Despatch of a communication from the examining division (Time limit: M06)
19.06.2004Reply to a communication from the examining division
30.09.2004Despatch of a communication from the examining division (Time limit: M02)
01.12.2004Reply to a communication from the examining division
17.01.2006Cancellation of oral proceeding that was planned for 18.01.2006
17.01.2006Minutes of oral proceedings despatched
18.01.2006Date of oral proceedings (cancelled)
27.03.2006Communication of intention to grant the patent
27.07.2006Fee for grant paid
27.07.2006Fee for publishing/printing paid
Opposition(s)23.08.2007No opposition filed within time limit [2007/44]
Fees paidRenewal fee
24.10.2001Renewal fee patent year 03
25.10.2002Renewal fee patent year 04
26.02.2004Renewal fee patent year 05
11.10.2004Renewal fee patent year 06
20.08.2005Renewal fee patent year 07
09.09.2006Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.10.200305   M06   Fee paid on   26.02.2004
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT22.11.2006
BE22.11.2006
CH22.11.2006
CY22.11.2006
FI22.11.2006
LI22.11.2006
NL22.11.2006
DK22.02.2007
SE22.02.2007
GR23.02.2007
PT23.04.2007
[2010/06]
Former [2008/21]AT22.11.2006
BE22.11.2006
CH22.11.2006
FI22.11.2006
LI22.11.2006
NL22.11.2006
DK22.02.2007
SE22.02.2007
GR23.02.2007
PT23.04.2007
Former [2008/18]AT22.11.2006
BE22.11.2006
CH22.11.2006
FI22.11.2006
LI22.11.2006
NL22.11.2006
DK22.02.2007
SE22.02.2007
PT23.04.2007
Former [2007/31]AT22.11.2006
BE22.11.2006
CH22.11.2006
FI22.11.2006
LI22.11.2006
NL22.11.2006
SE22.02.2007
Cited inInternational search[DPXL]WO9908658  (FUISZ TECHNOLOGIES LTD [US]) [DPX] 1-9 * the priority claim of the present application might not be justified; page 23 - page 24; example 5 *[L]
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.